Safety of retroviral gene marking with a truncated NGF receptor.
Bonini
C
C
Grez
M
M
Traversari
C
C
Ciceri
F
F
Marktel
S
S
Ferrari
G
G
Dinauer
M
M
Sadat
M
M
Aiuti
A
A
Deola
S
S
Radrizzani
M
M
Hagenbeek
A
A
Apperley
J
J
Ebeling
S
S
Martens
A
A
Kolb
H J
HJ
Weber
M
M
Lotti
F
F
Grande
A
A
Weissinger
E
E
Bueren
J A
JA
Lamana
M
M
Falkenburg
J H F
JH
Heemskerk
M H M
MH
Austin
T
T
Kornblau
S
S
Marini
F
F
Benati
C
C
Magnani
Z
Z
Cazzaniga
S
S
Toma
S
S
Gallo-Stampino
C
C
Introna
M
M
Slavin
S
S
Greenberg
P D
PD
Bregni
M
M
Mavilio
F
F
Bordignon
C
C
D000818:Animals; D016026:Bone Marrow Transplantation; D004285:Dogs; D005814:Genes, Viral; D005819:Genetic Markers; D005822:Genetic Vectors / Q000009:adverse effects*; D006801:Humans; D007938:Leukemia / Q000209:etiology / Q000517:prevention & control; D051379:Mice; D051381:Rats; D020800:Receptor, Nerve Growth Factor / Q000032:analysis*; D012190:Retroviridae / Q000235:genetics*; D014161:Transduction, Genetic
D005819:Genetic Markers; D020800:Receptor, Nerve Growth Factor